The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that largely affects elderly patients, drugmakers Sanofi and Regeneron announced ...

No Baby Blisters, a nonprofit organization dedicated to providing specialized aid to babies with epidermolysis bullosa, has announced a campaign to fund immediate medical care for affected families.

Some dermatologists might be inclined to simply refer patients with blistering skin diseases, which are relatively rare, to an expert center, but they should not waive the effort to reach a diagnosis ...

When you have eczema, red, inflamed patches of skin that itch intensely are common. But you might also sometimes have to contend with another type of outbreak — eczema blisters, which can cause ...